Natasha N. Campbell

Array ( [id] => 9440907 [patent_doc_number] => 08710017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-29 [patent_title] => 'Human and mouse targeting peptides identified by phage display' [patent_app_type] => utility [patent_app_number] => 13/286887 [patent_app_country] => US [patent_app_date] => 2011-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 44371 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13286887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776396 [patent_doc_number] => 20120039922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'METHOD AND PEPTIDE FOR REGULATING CELLULAR ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/284698 [patent_app_country] => US [patent_app_date] => 2011-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10326 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039922.pdf [firstpage_image] =>[orig_patent_app_number] => 13284698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8278431 [patent_doc_number] => 20120172305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'RETRO-INVERSO PEPTIDES DERIVED FROM INTERLEUKIN-6' [patent_app_type] => utility [patent_app_number] => 13/284617 [patent_app_country] => US [patent_app_date] => 2011-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6727 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13284617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228393 [patent_doc_number] => 20120142595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'TISSUE PROTECTIVE PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/278131 [patent_app_country] => US [patent_app_date] => 2011-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31308 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13278131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817489 [patent_doc_number] => 20120064109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'IMMUNOGENIC COMPOSITION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/268069 [patent_app_country] => US [patent_app_date] => 2011-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6575 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064109.pdf [firstpage_image] =>[orig_patent_app_number] => 13268069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8382204 [patent_doc_number] => 20120225826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'Transporters Comprising Spaced Arginine Moieties' [patent_app_type] => utility [patent_app_number] => 13/248783 [patent_app_country] => US [patent_app_date] => 2011-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11809 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13248783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8755239 [patent_doc_number] => 20130089545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'NOVEL COMPOUNDS AND THEIR EFFECTS ON FEEDING BEHAVIOUR' [patent_app_type] => utility [patent_app_number] => 13/240865 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 26498 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13240865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8476616 [patent_doc_number] => 20120276021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'USE OF REPEAT SEQUENCE PROTEIN POLYMERS IN PERSONAL CARE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/239793 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19977 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13239793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720798 [patent_doc_number] => 20120010133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent' [patent_app_type] => utility [patent_app_number] => 13/239696 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11930 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010133.pdf [firstpage_image] =>[orig_patent_app_number] => 13239696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9318411 [patent_doc_number] => 20140050749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'MHC-I Restricted Epitopes Containing Non-Natural Amino Acid Residues' [patent_app_type] => utility [patent_app_number] => 13/817261 [patent_app_country] => US [patent_app_date] => 2011-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25615 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9205923 [patent_doc_number] => 20140005100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION' [patent_app_type] => utility [patent_app_number] => 13/816393 [patent_app_country] => US [patent_app_date] => 2011-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27762 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10187604 [patent_doc_number] => 09217015 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-22 [patent_title] => 'Cyclosporin derivatives for the treatment and prevention of a viral infection' [patent_app_type] => utility [patent_app_number] => 13/810589 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24509 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10049656 [patent_doc_number] => 09089510 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-28 [patent_title] => 'A-β immunogenic peptide carrier conjugates and methods of producing same' [patent_app_type] => utility [patent_app_number] => 13/178428 [patent_app_country] => US [patent_app_date] => 2011-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25438 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13178428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501520 [patent_doc_number] => 20110263516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'VASODILATOR' [patent_app_type] => utility [patent_app_number] => 13/175340 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2760 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263516.pdf [firstpage_image] =>[orig_patent_app_number] => 13175340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561757 [patent_doc_number] => 20110275590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'CONJUGATES FOR CANCER THERAPY AND DIAGNOSIS' [patent_app_type] => utility [patent_app_number] => 13/164204 [patent_app_country] => US [patent_app_date] => 2011-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15941 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275590.pdf [firstpage_image] =>[orig_patent_app_number] => 13164204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502204 [patent_doc_number] => 20110263818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Peptidic Constructs with Amino Acid Surrogates' [patent_app_type] => utility [patent_app_number] => 13/162669 [patent_app_country] => US [patent_app_date] => 2011-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42712 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263818.pdf [firstpage_image] =>[orig_patent_app_number] => 13162669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6090333 [patent_doc_number] => 20110218142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'Inhibitors of Dipeptidylpeptidase IV' [patent_app_type] => utility [patent_app_number] => 13/108461 [patent_app_country] => US [patent_app_date] => 2011-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25313 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218142.pdf [firstpage_image] =>[orig_patent_app_number] => 13108461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574020 [patent_doc_number] => 20110269676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'BIFUNCTIONAL MOLECULES FOR INACTIVATING HIV AND BLOCKING HIV ENTRY' [patent_app_type] => utility [patent_app_number] => 13/100031 [patent_app_country] => US [patent_app_date] => 2011-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8747 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269676.pdf [firstpage_image] =>[orig_patent_app_number] => 13100031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846267 [patent_doc_number] => 08455448 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Myostatin isoform' [patent_app_type] => utility [patent_app_number] => 13/085263 [patent_app_country] => US [patent_app_date] => 2011-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 24053 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13085263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490096 [patent_doc_number] => 20110237503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'NOVEL PEPTIDES AND METHODS FOR THEIR PREPARATION AND USE' [patent_app_type] => utility [patent_app_number] => 13/069425 [patent_app_country] => US [patent_app_date] => 2011-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9509 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237503.pdf [firstpage_image] =>[orig_patent_app_number] => 13069425 [rel_patent_id] =>[rel_patent_doc_number] =>)